(Q33342383)

26 July 2017

1 reference

title

What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia? (English)

1 reference

26 July 2017

1 reference

1 reference

1 reference

Richard J Benjamin

1

1 reference

26 July 2017

Kenneth C Anderson

series ordinal

2

1 reference

26 July 2017

publication date

1 May 2002

1 reference

Critical Reviews in Oncology Hematology

26 July 2017

published in

1 reference

26 July 2017

volume

42

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

163-171

1 reference

Collection and transfusion of blood and blood components in the United States, 1994

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Controversies in transfusion medicine. Prophylactic platelet transfusion revisited after 25 years: con

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Prophylactic platelet transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

The Prophylactic Treatment of Thrombocytopenic Leukemic Patients with Platelets: a Double Blind Study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Prophylactic Platelet Transfusions in Children with Acute Leukemia: A Dose Response Study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Indications for platelet transfusion in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Platelet prophylaxis in acute non-lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Platelet Transfusion Requirements of Children with Newly Diagnosed Lymphoblastic Leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Some aspects of recent advances in the use of blood cell components

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Controversies in transfusion medicine. Prophylactic platelet transfusion therapy: pro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

The quantitative relation between platelet count and hemorrhage in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Final statement from the consensus conference on platelet transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

THE RELATION OF BLOOD PLATELETS TO HEMORRHAGIC DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

The bleeding time as a screening test for evaluation of platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Incidence of hemorrhagic complications in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Conservative Management of Chemotherapeutic-Induced Thrombocytopenia in Women with Gynecologic Cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

Lowering the prophylactic platelet transfusion threshold: a prospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900182-2

7 January 2021

10.1016/S1040-8428(01)00182-2

Identifiers

DOI

1 reference

26 July 2017

1 reference